• Interlab acquired 650,000 Series A shares in Biohit on October 27, 2026.
• The purchase raised Osmo Suovaniemi and his controlled company Interlab's combined stake to 28.27%, with 81.96% of voting rights.
• Their previously disclosed holdings represented 22.69% of shares and 58.27% of votes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biohit Oyj published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.